EQS-Adhoc: Cherry SE: Sale of a business segment planned
Werte in diesem Artikel
|
EQS-Ad-hoc: CHERRY SE / Key word(s): Mergers & Acquisitions Werbung Werbung Munich, November 19, 2025 – The Management Board of Cherry SE today decided to initiate an M&A process for the sale of one of its two business segments, "Digital Health & Solutions" or "Peripherals". The "Digital Health & Solutions" business segment comprises e-health terminals, mobile devices, firmware, software and cloud solutions such as TI-M or TMS. The "Peripherals" business segment consists of a comprehensive product portfolio of gaming devices as well as office, industrial, and security peripherals.
The background to the Management Board’s decision is the continuing constraints on financial flexibility despite the restructuring measures already implemented. The liquidity generated from the sale is intended to be used to reduce liabilities and provide the remaining part of the business with sufficient financial resources to finance its growth plans. Notifying person: Oliver Kaltner, Chairman of the Board End of Inside Information
19-Nov-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | Cherry SE |
| Rosental 7, c/o Mindspace | |
| 80331 Munich | |
| Germany | |
| ISIN: | DE000A3CRRN9 |
| WKN: | A3CRRN |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 2232776 |
| End of Announcement | EQS News Service |
|
|
2232776 19-Nov-2025 CET/CEST
Ausgewählte Hebelprodukte auf CHERRY
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf CHERRY
Der Hebel muss zwischen 2 und 20 liegen
| Name | Hebel | KO | Emittent |
|---|
| Name | Hebel | KO | Emittent |
|---|
Nachrichten zu CHERRY
Analysen zu CHERRY
Keine Analysen gefunden.